Back
M
Ministry of Public Health
Scholars135
Papers63
Citations0
Related Papers (58)
Publication Date
Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults
Vaccines
IF3.4

